Picture of Fredun Pharmaceuticals logo

539730 Fredun Pharmaceuticals Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Momentum

Relative Strength (%)
1m-15.85%
3m-19.84%
6m-26.23%
1yr-32.77%
Volume Change (%)
10d/3m+57.39%
Price vs... (%)
52w High-41.24%
50d MA-11.68%
200d MA-16.47%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital25.48%
Return on Equity14.89%
Operating Margin10.88%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m963.171,127.861,315.522,217.372,743.42n/an/a36.42%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+55.7-58.86+44.37+106.73+61.99n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Fredun Pharmaceuticals EPS forecast chart

Profile Summary

Fredun Pharmaceuticals Ltd. is an India-based pharmaceutical company. The Company is primarily engaged in the business of pharmaceuticals and healthcare. The Company operates through four segments: Generics (Exports & Fredun Gx), Pet Healthcare (Freossi), Nutraceuticals (Fredun Nutrition) and Cosmeceuticals (Bird and Beauty or BnB). It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It is also engaged in the manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with animal healthcare products. The Company primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
June 8th, 1987
Public Since
March 17th, 2016
No. of Shareholders
4,521
No. of Employees
260
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
4,699,162

539730 Share Price Performance

Upcoming Events for 539730

Q4 2024 Fredun Pharmaceuticals Ltd Earnings Release

Q1 2025 Fredun Pharmaceuticals Ltd Earnings Release

Similar to 539730

Picture of Achyut Healthcare logo

Achyut Healthcare

in flag iconBombay Stock Exchange

Picture of Adline Chem Lab logo

Adline Chem Lab

in flag iconBombay Stock Exchange

Picture of MPS Pharmaa logo

MPS Pharmaa

in flag iconBombay Stock Exchange

Picture of Albert David logo

Albert David

in flag iconBombay Stock Exchange

Picture of Ambalal Sarabhai Enterprises logo

Ambalal Sarabhai Enterprises

in flag iconBombay Stock Exchange

FAQ